Photonic Liposomes
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 July 2019) | Viewed by 469
Special Issue Editor
Interests: gene therapy (of oral cancer); photodynamic therapy (of oral cancer); bacteriophage therapy (of mycobacterium infections); HIV eradication (via suicide gene therapy); nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Pharmaceutics Issue on “Photonic Liposomes” will cover all aspects of the interaction of photons with molecules embedded in liposomes that can respond to the photons to become functional, especially for therapeutic purposes. Such liposomes may respond to photonic activation to release their contents, which may include anti-cancer drugs, or certain photosensitizers in the liposomes targeted to tumors may generate reactive oxygen species upon activation and kill cancer cells. We welcome articles that describe the biophysics of photon-induced changes in the molecular structure of liposomal lipids or focus on the therapeutic application of either type of photonic liposomes. We expect that the Issue will include both original research articles and reviews.
Prof. Nejat Duzgunes
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- light-sensitive
- photodynamic therapy
- liposomes
- cancer therapy
- antimicrobial therapy
- liposome permeability
- photosensitizer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
